Digital Medicine

We work with founders to build companies leveraging AI, machine learning and data analytics to transform healthcare and medicine.

Our approach is evidence-based, rooted in rigorous scientific research and clinical validation and builds on Sofinnova's 50 years of experience in the life sciences sector.

CloseFundAMT
2023Sofinnova Digital Medicine I$200 million
  • Close: 2023

    Fund: Sofinnova Digital Medicine I

    AMT: $200 million

"We bring our experience in biological innovation coupled with powerful computing and AI capabilities to build deeply technical companies to product-market fit. This is what makes our approach unique."

"We designed this strategy to help founders leverage our knowledge of a highly-regulated and complex healthcare industry while drawing on the strengths of tech-industry approaches like rapid product iteration and swift commercialization."

Companies

Fund iteration
Status
Deal lead

Join our mailing list

Keep up to date with our latest news.

Required
Thanks for submitting the form. You are now subscribed to Sofinnova Partners news alerts.An error happened. Please try again later.